Using market leverage on drug prices could save Washington state up to $1.2 billion

cheap-prescription-drugsAmericans pay far higher prices for prescription drugs than do people in other wealthy countries. The reason that other countries spend so much less on drugs is that their governments negotiate prices with the pharmaceutical industry. The United States government could adopt the same approach with the Medicare drug program and use its market leverage to negotiate the same, or even lower, prices as are paid by other wealthy nations.

According to a new issue brief from Center for Economic Policy and Research, such a system would save Washington state between $500 million and $1.2 billion over 10 years. The potential savings to all states would be enormous, cumulatively between $31 billion and $73 billion over 10 years.

Every state individually could expect significant savings. California leads the way, with potential savings between $3.3 and $7.8 billion. The next six top-saving states are Florida, New York, Texas, Pennsylvania, Ohio and Illinois, all with projected savings of at least $1 billion per year. Even those states with the least potential savings, such as Wyoming, North Dakota and Vermont, would still save tens of millions of dollars over a decade.

Get state by state data and more from CEPR here »

  • Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More To Read

February 11, 2025

The rising cost of health care is unsustainable and out of control

We have solutions that put people over profits

January 29, 2025

Who is left out of the Paid Family and Medical Leave Act?

Strengthening job protections gives all workers time they need to care for themselves and their families

January 17, 2025

A look into the Department of Revenue’s Wealth Tax Study

A wealth tax can be reasonably and effectively implemented in Washington state